Neomycin, but Not Neamine, Blocks Angiogenic Factor Induced Nitric Oxide Release through Inhibition of Akt Phosphorylation
Angiogenesis, the growth of new blood vessels, is a critical factor of carcinogenesis. Neomycin and neamine, two drugs blocking the nuclear translocation of angiogenin (ANG), have been proven to inhibit tumour growth in vivo. However, the high toxicity of neomycin prevents its therapeutic use, thus...
Main Authors: | Raphaël Trouillon, Dong-Ku Kang, Soo-Ik Chang, Danny O’Hare |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/23/15277 |
Similar Items
-
Hypoxia Increases Nitric Oxide-Dependent Inhibition of Angiogenic Growth
by: Cristina Arce, et al.
Published: (2021-12-01) -
Inhaled Nitric Oxide Promotes Angiogenesis in the Rodent Developing Brain
by: Gauthier Loron, et al.
Published: (2023-03-01) -
The Role of Nitric Oxide in Cancer: Master Regulator or NOt?
by: Faizan H. Khan, et al.
Published: (2020-12-01) -
The Utility of the Nitric Oxide Electrochemical Sensor in Biomedical Research
by: John B. Clark, et al.
Published: (2003-08-01) -
Targeting Anti-Angiogenic VEGF<sub>165</sub>b–VEGFR1 Signaling Promotes Nitric Oxide Independent Therapeutic Angiogenesis in Preclinical Peripheral Artery Disease Models
by: Sivaraman Kuppuswamy, et al.
Published: (2022-08-01)